{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:23:31Z","timestamp":1792290211837,"version":"4.4.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>In light of the absence of rapid and precise diagnostic laboratory tests for the detection of <jats:italic>Mycoplasma pneumoniae<\/jats:italic> (MP), a prominent etiological agent implicated in a range of respiratory infections, we developed and evaluated a rapid and straightforward loop-mediated isothermal amplification (LAMP) assay targeting the MP community-acquired respiratory distress syndrome toxin (CARDS TX) gene. The LAMP assay was performed at 65\u00b0C for a duration of 60 min, yielding a minimum detection concentration of MP CARDS TX at 0.4986 pg\/\u03bcl. The assay exhibited no cross-reactivity with 13 other prevalent pathogens associated with respiratory infections or with other common bacterial toxin genes. To further substantiate the validity of the LAMP assay, 200 pharyngeal swabs or bronchoalveolar lavage (BAL) samples were collected from inpatients diagnosed with community-acquired pneumonia (CAP) between June 2021 and July 2022. The results were compared with those obtained by the quantitative real-time polymerase chain reaction (qPCR) method for verification purposes. Of the 200 clinical specimens, 11 exhibited positive results for MP by LAMP and 10 displayed positive results for MP by qPCR (<jats:italic>P<\/jats:italic> = 1.000). In summary, a sensitive, specific, straightforward, and expeditious LAMP method for CARDS TX identification was developed to facilitate rapid detection of MP in point-of-care settings. This assay enables early and accurate diagnosis, even in resource-limited environments, which is important for proper antibiotic treatment and prognosis of MP infection.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1496829","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:16:41Z","timestamp":1741151801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Rapid detection of Mycoplasma pneumoniae CARDS toxin in clinical respiratory specimens by a loop-mediated isothermal amplification assay"],"prefix":"10.3389","volume":"15","author":[{"given":"Yun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbiao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"B1","first-page":"853","article-title":"Membranous nephropathy associated with Mycoplasma pneumoniae infection","volume-title":"Pediatr. Int","author":"Aizawa","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12879-019-3799-4","article-title":"Diagnosis of mycoplasma pneumoniae by loop-mediated isothermal amplification: systematic review and meta-analysis","volume":"19","author":"Cai","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00134-016-4394-4","article-title":"Community-acquired pneumonia related to intracellular pathogens","volume":"42","author":"Cill\u00f3niz","year":"2016","journal-title":"Intensive Care Med."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02751","article-title":"Pathogenesis and treatment of neurologic diseases associated with Mycoplasma pneumoniae infection","volume":"9","author":"D\u2019Alonzo","year":"2018","journal-title":"Front. Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3988\/jcn.2022.0328","article-title":"Determining the clinical characteristics, treatment strategies, and prognostic factors for mycoplasma pneumoniae encephalitis in children: A multicenter study in China","volume":"19","author":"Fan","year":"2023","journal-title":"J. Clin. Neurol. Seoul Korea"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2019.105731","article-title":"Can sputum gram stain be used to predict lower respiratory tract infection and guide empiric antimicrobial treatment: Experience from a tertiary care hospital","volume":"166","author":"Gunasekaran","year":"2019","journal-title":"J. Microbiol. Methods"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1165586","article-title":"Investigating the occurrence of autoimmune diseases among children and adolescents hospitalized for Mycoplasma pneumoniae infections","volume":"14","author":"Ha","year":"2023","journal-title":"Front. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/infdis\/173.6.1445","article-title":"Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients","volume":"173","author":"Ieven","year":"1996","journal-title":"J. Infect. Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020119","article-title":"Mycoplasma pneumoniae infections: pathogenesis and vaccine development","volume":"10","author":"Jiang","year":"2021","journal-title":"Pathog. Basel Switz."},{"key":"B11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/ped.12327","article-title":"Genetic point-of-care diagnosis of Mycoplasma pneumoniae infection using LAMP assay","volume":"56","author":"Kakuya","year":"2014","journal-title":"Pediatr. Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1128\/IAI.73.5.2828-2834.2005","article-title":"). Identification and characterization of human surfactant protein A binding protein of mycoplasma pneumoniae","volume":"73","author":"Kannan","year":"2005","journal-title":"Infect. Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1111\/jdv.16796","article-title":"Mycoplasma pneumoniae-associated Stevens-Johnson syndrome: characteristic histological features of mucosal lesion","volume":"35","author":"Katsumi","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107205","article-title":"Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in Asia-Pacific region","volume":"64","author":"Lai","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","article-title":"Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"16","author":"Lee","year":"2018","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","article-title":"High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia","volume":"25","author":"Li","year":"2019","journal-title":"Mol. Med. Camb. Mass"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104893","article-title":"Mycoplasma pneumoniae infection and risk of childhood asthma: A systematic review and meta-analysis","volume":"155","author":"Liu","year":"2021","journal-title":"Microb. Pathog."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00448","article-title":"Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics","volume":"7","author":"Loens","year":"2016","journal-title":"Front. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3760\/cmaj.issn.2095-428X.2018.22.006","article-title":"Clinical Significance of the measurement of toxin level of community-acquired respiratory distress syndrome in children with Mycoplasma pneumoniae pneumonia","volume":"33","author":"Ma","year":"2018","journal-title":"Zhonghua Shi Yong Er Ke Lin Chuang Za Zhi."},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1165\/rcmb.2017-0006OC","article-title":"The immunopathologic effects of mycoplasma pneumoniae and community-acquired respiratory distress syndrome toxin. A primate model","volume":"58","author":"Maselli","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1165\/rcmb.2011-0135OC","article-title":"Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation","volume":"46","author":"Medina","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jiac.2019.07.020","article-title":"Loop-mediated isothermal amplification (LAMP): Expansion of its practical application as a tool to achieve universal health coverage","volume":"26","author":"Mori","year":"2020","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12890-020-01275-8","article-title":"Pathogenic characteristics of sputum and bronchoalveolar lavage fluid samples from patients with lower respiratory tract infection in a large teaching hospital in China: a retrospective study","volume":"20","author":"Peng","year":"2020","journal-title":"BMC Pulm Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.11-0221","article-title":"Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma","volume":"140","author":"Peters","year":"2011","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103863","article-title":"Mycoplasma pneumoniae-related hepatitis in children","volume":"139","author":"Poddighe","year":"2020","journal-title":"Microb. Pathog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"11571","DOI":"10.1038\/s41598-021-90948-3","article-title":"Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities","volume":"11","author":"Ramasamy","year":"2021","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1099\/jmm.0.46071-0","article-title":"Development and evaluation of a loop-mediated isothermal amplification assay for rapid detection of Mycoplasma pneumoniae","volume":"54","author":"Saito","year":"2005","journal-title":"J. Med. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Sauteur","year":"2024","journal-title":"Lancet Microbe"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.766591","article-title":"Community-acquired respiratory distress syndrome toxin: unique exotoxin for M. pneumoniae","volume":"12","author":"Su","year":"2021","journal-title":"Front. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3201\/eid2310.170106","article-title":"Macrolide-resistant mycoplasma pneumoniae infection, Japan 2008-2015","volume":"23","author":"Tanaka","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1097\/MPH.0000000000001001","article-title":"Severe warm autoimmune hemolytic anemia in a 7-month-old infant associated with a mycoplasma pneumoniae infection","volume":"40","author":"Wandro","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","article-title":"Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020","volume":"11","author":"Wang","year":"2022","journal-title":"Emerging Microbes Infections"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066721","article-title":"Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13568-019-0921-3","article-title":"Development of loop-mediated isothermal amplification coupled with nanoparticle-based lateral flow biosensor assay for Mycoplasma pneumoniae detection","volume":"9","author":"Wang","year":"2019","journal-title":"AMB Express"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/jac\/dkac170","article-title":"Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis","volume":"77","author":"Wang","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2021:8085530","DOI":"10.1155\/2021\/8085530.eCollection2021","article-title":"Chest CT Findings and Differential Diagnosis of Mycoplasma pneumoniae Pneumonia and Mycoplasma pneumoniae Combined with Streptococcal Pneumonia in Children","volume":"14","author":"Wang","year":"2021","journal-title":"J. Healthc. Eng."},{"key":"B38","first-page":"4009","article-title":"Evaluation of bronchoalveolar lavage fluid combined with the loop-mediated isothermal amplification assay in lower respiratory tract infections","volume":"12","author":"Wang","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2471","article-title":"Advances in the causes and management of community acquired pneumonia in adults","volume":"358","author":"Wunderink","year":"2017","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.882855","article-title":"Loop-mediated isothermal amplification coupled with nanoparticle-based biosensor: A rapid and sensitive method to detect mycoplasma pneumoniae","volume":"12","author":"Xiao","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106865","article-title":"Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins","volume":"195","author":"Xu","year":"2024","journal-title":"Microb. Pathog."},{"key":"B42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-019-0576-5","article-title":"Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China","volume":"8","author":"Zhao","year":"2019","journal-title":"Antimicrobial Resistance Infection Control"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1347885","article-title":"A Case Report of Mycoplasma pneumoniae-induced fulminant myocarditis in a 15-year-old male leading to cardiogenic shock and electrical storm","volume":"11","author":"Zhu","year":"2024","journal-title":"Front. Cardiovasc. Med."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1496829\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:03:47Z","timestamp":1742375027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1496829\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":43,"alternative-id":["10.3389\/fcimb.2025.1496829"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1496829","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1496829"}}